Evidence Hub

A case of bilateral linear and annular lupus panniculitis following Blaschko's lines in a child

Li-Xin Chen, Ying Wang, Hong-Wei Fang, Hai-Hui Su

Australasian Journal of Dermatology, 2023

1 citation

Abstract

REFERENCES 1. Anhalt GJ. Paraneoplastic pemphigus. J Investing Dermatol Symp Proc. 2004;9:29– 33. 2. Fardet L, Petersen I, Nazareth I. Common infections in patients prescribed systemic glucocorticoids in primary care: a populationbased cohort study. PLoS Med. 2016;13:e1002024. https://doi.org/10.1371/journ al.pmed.1002024 3. Leger S, Picard D, IngenHouszOro S, Arnault JP, Aubin F, Carsuzaa F, et al. Prognostic factors of paraneoplastic pemphigus. Arch Dermatol. 2012;148:1165– 72. 4. Monshi B, Ellersdorfer C, Edelmayer M, Dvorak G, Ganger C, Ulm C, et al. Topical cyclosporine in oral lichen planus— a series of 21 openlabel, biphasic, singlepatient observations. J Clin Med. 2021;10:5454. 5. Eisen D, Ellis CN. Topical cyclosporine for oral mucosal disorders. J Am Acad Dermatol. 1990;23:1259– 63.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free